Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JANUARY 24, 2024 SAM #8093
SOURCES SOUGHT

99 -- Access to Inpatient Pediatric Drug Utilization Data � Request for Information

Notice Date
1/22/2024 6:26:56 AM
 
Notice Type
Sources Sought
 
Contracting Office
FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
 
ZIP Code
20705
 
Solicitation Number
FDA-RFI-CDER-2024-121421
 
Response Due
2/15/2024 9:00:00 AM
 
Archive Date
03/01/2024
 
Point of Contact
Maeve Xavier, Phone: 2404027609
 
E-Mail Address
maeve.xavier@fda.hhs.gov
(maeve.xavier@fda.hhs.gov)
 
Description
Purpose THIS IS A REQUEST FOR INFORMATION (RFI) ONLY. This Request for Information (RFI) is being issued in accordance with Federal Acquisition Regulation Part 10, Market Research. It is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand industry best practices, technical solutions, and sources capable of meeting the FDA's requirements for evaluating pediatric drug utilization data. Specifically, the Government is seeking verification that its automated, auditable, quantitative data mining requirement is commercially available, and determine if there are any questions about the FDA's requirements. The government would also like to determine if there are any gaps in pediatric data available to meet the FDA's requirements. Background The FDA has access to multiple drug utilization databases, some of which contain pediatric use patterns, but gaps remain in our ability to fully characterize pediatric drug use nationwide. Information is lacking from stand-alone pediatric hospitals, where medically complex children may receive different therapeutic treatments compared to children treated in general hospitals or in outpatient settings. Identifying data sources to support a more comprehensive view of nationally representative inpatient pediatric drug utilization patterns could greatly improve our understanding of how drugs are being prescribed to children under real-world conditions to support FDA�s mission. Objectives The Agency would like to determine sources available to provide continuous access to data containing pediatric inpatient drug utilization, including pediatric specialty hospitals and Emergency Departments (ED) and, if available, treatment procedures and diagnostic information in pediatric patients. Information Requested Interested parties should provide responses to the following questions (where available) regarding their data sources. Responses to this Request for Information shall be sent to Maeve Xavier, Contract Specialist via email at Maeve.Xavier@fda.hhs.gov as one (1) attachment (Microsoft Word or Adobe Acrobat formats only). The attachment shall be on 8.5� x 11� pages, with 12-point font size in Times New Roman (or equivalent) and single-spaced. Responses should be limited to 10 pages or less. The email subject line shall read, �FDA-RFI-CDER-2024-121421 � Access to Inpatient Pediatric Drug Utilization Data - __________ (enter name of your company.)� No other information other than what is specifically outlined this section shall be submitted. Please forward all responses to this RFI by the Response Date of Thursday February 15, 2024, no later than 12:00 PM Eastern.. Responses received after the due date may not be considered. Be advised that FDA does not accept documents which contain the use of macros. When submitting documents via email, DO NOT include .exe, .mso, or any other executable file types that could potentially trigger email security protections (i.e. email blocks, quarantine). Document submissions shall not have macro enabled functionality and any document delivered having that functionality will be deemed delinquent, if not corrected prior to the due date.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/0f725f8122ae42f8a00a512a6acea91e/view)
 
Place of Performance
Address: Silver Spring, MD 20993, USA
Zip Code: 20993
Country: USA
 
Record
SN06941908-F 20240124/240122230047 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.